- Home
- Venture Capital
- Life Sciences
- Portfolio
Portfolio
Portfolio Venture Capital - Life Sciences
-
Company: 7TM Pharma
Country: Denmark
Business unit: Venture Capital - Life Sciences -
Company: Ablynx
Country: Belgium
Business unit: Venture Capital - Life Sciences -
Company: Acertys Group
Country: Belgium
Business unit: Buyouts & Growth - Belgium, Venture Capital - Life Sciences -
Company: ActoGenix
Country: Belgium
Business unit: Venture Capital - Life Sciences -
Company: Ambit
Country: USA
Business unit: Venture Capital - Life Sciences -
Company: Antisoma (former Xanthus)
Country: USA
Business unit: Venture Capital - Life Sciences -
Company: Astex Therapeutics
Country: UK
Business unit: Venture Capital - Life Sciences -
Company: Ceres
Country: USA
Business unit: Venture Capital - Life Sciences, Venture Capital - Cleantech -
Company: ChemoCentryx
Country: USA
Business unit: Venture Capital - Life Sciences -
Company: Endosense
Country: Switzerland
Business unit: Venture Capital - Life Sciences -
Company: Innate Pharma
Country: France
Business unit: Venture Capital - Life Sciences -
Company: JenaValve
Country: Germany
Business unit: Venture Capital - Life Sciences -
Company: Movetis
Country: Belgium
Business unit: Venture Capital - Life Sciences -
Company: Nereus Pharmaceuticals
Country: USA
Business unit: Venture Capital - Life Sciences -
Company: PamGene
Country: Netherlands
Business unit: Venture Capital - Life Sciences -
Company: Plexxikon
Country: USA
Business unit: Venture Capital - Life Sciences -
Company: Pronota
Country: Belgium
Business unit: Venture Capital - Life Sciences -
Company: Prosensa
Country: Netherlands
Business unit: Venture Capital - Life Sciences -
Company: Santhera Pharmaceuticals
Country: Switzerland
Business unit: Venture Capital - Life Sciences
-
Company: ACLARA BioSciences
Country: USA
Business unit: Venture Capital - Life Sciences -
Company: ArQule
Country: USA
Business unit: Venture Capital - Life Sciences -
Company: Arrow Therapeutics
Country: UK
Business unit: Venture Capital - Life Sciences -
Company: Avalon Pharmaceuticals
Country: USA
Business unit: Venture Capital - Life Sciences -
Company: Connetics
Country: USA
Business unit: Venture Capital - Life Sciences -
Company: Corvas
Country: USA
Business unit: Venture Capital - Life Sciences -
Company: CropDesign
Country: Belgium
Business unit: Venture Capital - Life Sciences -
Company: Crucell
Country: Netherlands
Business unit: Venture Capital - Life Sciences -
Company: Devgen
Country: Belgium
Business unit: Venture Capital - Life Sciences -
Company: Evotec
Country: Germany
Business unit: Venture Capital - Life Sciences -
Company: Exelixis
Country: USA
Business unit: Venture Capital - Life Sciences -
Company: Galápagos
Country: Belgium
Business unit: Venture Capital - Life Sciences -
Company: Gene Logic
Country: USA
Business unit: Venture Capital - Life Sciences -
Company: Fovea Pharmaceuticals
Country: France
Business unit: Venture Capital - Life Sciences -
Company: Hypnion
Country: USA
Business unit: Venture Capital - Life Sciences -
Company: Innogenetics
Country: Belgium
Business unit: Venture Capital - Life Sciences -
Company: IsoTis
Country: USA
Business unit: Venture Capital - Life Sciences -
Company: Memory Pharmaceuticals
Country: USA
Business unit: Venture Capital - Life Sciences -
Company: Plant Genetic Systems
Country: Belgium
Business unit: Venture Capital - Life Sciences -
Company: Torreypines Therapeutics
Country: USA
Business unit: Venture Capital - Life Sciences -
Company: ThromboGenics
Country: Belgium
Business unit: Venture Capital - Life Sciences -
Company: Telik
Country: USA
Business unit: Venture Capital - Life Sciences -
Company: Triangle Pharmaceuticals
Country: USA
Business unit: Venture Capital - Life Sciences